These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
367 related items for PubMed ID: 19090868
1. Correlates affecting survival in chronic hemodialysis patients: the combined impact of albumin and high hemoglobin levels on improving outcomes, local and national results. Capelli JP, Kushner H. Hemodial Int; 2008 Oct; 12(4):450-62. PubMed ID: 19090868 [Abstract] [Full Text] [Related]
2. Anemia management and association of race with mortality and hospitalization in a large not-for-profit dialysis organization. Servilla KS, Singh AK, Hunt WC, Harford AM, Miskulin D, Meyer KB, Bedrick EJ, Rohrscheib MR, Tzamaloukas AH, Johnson HK, Zager PG. Am J Kidney Dis; 2009 Sep; 54(3):498-510. PubMed ID: 19628315 [Abstract] [Full Text] [Related]
3. Associations between changes in hemoglobin and administered erythropoiesis-stimulating agent and survival in hemodialysis patients. Regidor DL, Kopple JD, Kovesdy CP, Kilpatrick RD, McAllister CJ, Aronovitz J, Greenland S, Kalantar-Zadeh K. J Am Soc Nephrol; 2006 Apr; 17(4):1181-91. PubMed ID: 16565261 [Abstract] [Full Text] [Related]
4. The importance of serum albumin and phosphorous as predictors of mortality in ESRD patients. Phelan PJ, O'Kelly P, Walshe JJ, Conlon PJ. Ren Fail; 2008 Apr; 30(4):423-9. PubMed ID: 18569917 [Abstract] [Full Text] [Related]
5. Effect of variability in anemia management on hemoglobin outcomes in ESRD. Lacson E, Ofsthun N, Lazarus JM. Am J Kidney Dis; 2003 Jan; 41(1):111-24. PubMed ID: 12500228 [Abstract] [Full Text] [Related]
6. Serum ferritin is a marker of morbidity and mortality in hemodialysis patients. Kalantar-Zadeh K, Don BR, Rodriguez RA, Humphreys MH. Am J Kidney Dis; 2001 Mar; 37(3):564-72. PubMed ID: 11228181 [Abstract] [Full Text] [Related]
7. Associates of mortality and hospitalization in hemodialysis: potentially actionable laboratory variables and vascular access. Lacson E, Wang W, Hakim RM, Teng M, Lazarus JM. Am J Kidney Dis; 2009 Jan; 53(1):79-90. PubMed ID: 18930570 [Abstract] [Full Text] [Related]
8. The effect of on-line high-flux hemofiltration versus low-flux hemodialysis on mortality in chronic kidney failure: a small randomized controlled trial. Santoro A, Mancini E, Bolzani R, Boggi R, Cagnoli L, Francioso A, Fusaroli M, Piazza V, Rapanà R, Strippoli GF. Am J Kidney Dis; 2008 Sep; 52(3):507-18. PubMed ID: 18617304 [Abstract] [Full Text] [Related]
9. [Late nephrology referral influences on morbidity and mortality of hemodialysis patients. A provincial study]. Peña JM, Logroño JM, Pernaute R, Laviades C, Virto R, Vicente de Vera C. Nefrologia; 2006 Sep; 26(1):84-97. PubMed ID: 16649429 [Abstract] [Full Text] [Related]
10. Biocompatibility and permeability of dialyzer membranes do not affect anemia, erythropoietin dosage or mortality in japanese patients on chronic non-reuse hemodialysis: a prospective cohort study from the J-DOPPS II study. Yokoyama H, Kawaguchi T, Wada T, Takahashi Y, Higashi T, Yamazaki S, Fukuhara S, Akiba T, Akizawa T, Asano Y, Kurokawa K, Saito A, J-DOPPS Research Group. Nephron Clin Pract; 2008 Sep; 109(2):c100-8. PubMed ID: 18596379 [Abstract] [Full Text] [Related]
11. Anemia treatment in the pre-ESRD period and associated mortality in elderly patients. Xue JL, St Peter WL, Ebben JP, Everson SE, Collins AJ. Am J Kidney Dis; 2002 Dec; 40(6):1153-61. PubMed ID: 12460033 [Abstract] [Full Text] [Related]
12. Association between hematocrit level and mortality in hemodialysis patients. Case study of the anemic patient. Collins A, Ellefson J. Nephrol Nurs J; 2000 Apr; 27(2):233-6. PubMed ID: 11111551 [Abstract] [Full Text] [Related]
13. Greater Epoetin alfa (EPO) doses and short-term mortality risk among hemodialysis patients with hemoglobin levels less than 11 g/dL. Bradbury BD, Do TP, Winkelmayer WC, Critchlow CW, Brookhart MA. Pharmacoepidemiol Drug Saf; 2009 Oct; 18(10):932-40. PubMed ID: 19572312 [Abstract] [Full Text] [Related]
14. Effect of anemia and hyperhomocysteinemia on mortality of patients on hemodialysis. Anees M, Mumtaz A, Ibrahim M, Shaheen SM, Asghar A. Iran J Kidney Dis; 2010 Jan; 4(1):60-5. PubMed ID: 20081306 [Abstract] [Full Text] [Related]
15. Potential impact of nutritional intervention on end-stage renal disease hospitalization, death, and treatment costs. Lacson E, Ikizler TA, Lazarus JM, Teng M, Hakim RM. J Ren Nutr; 2007 Nov; 17(6):363-71. PubMed ID: 17971308 [Abstract] [Full Text] [Related]
16. [DOPPS estimate of patient life years attributable to modifiable hemodialysis practices in Spain]. Piera L, Cruz JM, Braga-Gresham JL, Eichleay MA, Pisoni RL, Port FK. Nefrologia; 2007 Nov; 27(4):496-504. PubMed ID: 17944588 [Abstract] [Full Text] [Related]
17. Renal amyloidosis is associated with increased mortality in hemodialysis patients. Sengul S, Arat Z, Ozdemir FN. Artif Organs; 2004 Sep; 28(9):846-52. PubMed ID: 15320948 [Abstract] [Full Text] [Related]
18. Association of predialysis serum bicarbonate levels with risk of mortality and hospitalization in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Bommer J, Locatelli F, Satayathum S, Keen ML, Goodkin DA, Saito A, Akiba T, Port FK, Young EW. Am J Kidney Dis; 2004 Oct; 44(4):661-71. PubMed ID: 15384017 [Abstract] [Full Text] [Related]
19. The "right" of passage: surviving the first year of dialysis. Wingard RL, Chan KE, Lazarus JM, Hakim RM. Clin J Am Soc Nephrol; 2009 Dec; 4 Suppl 1():S114-20. PubMed ID: 19995993 [Abstract] [Full Text] [Related]
20. Haemoglobin at time of referral prior to dialysis predicts survival: an association of haemoglobin with long-term outcomes. Levin A, Djurdjev O, Duncan J, Rosenbaum D, Werb R. Nephrol Dial Transplant; 2006 Feb; 21(2):370-7. PubMed ID: 16249203 [Abstract] [Full Text] [Related] Page: [Next] [New Search]